Literature DB >> 10583930

Relevance of apolipoprotein E polymorphism for coronary artery disease in the Saudi population.

N Dzimiri1, B F Meyer, S S Hussain, C Basco, B Afrane, Z Halees.   

Abstract

BACKGROUND: The apolipoprotein E alleles epsilon2 and epsilon4 have been reported as independent risk factors for coronary artery disease (CAD) and as predictors for the development of atherosclerosis. METHODS AND
RESULTS: We determined by polymerase chain reaction the distribution of apolipoprotein E polymorphism in 320 Saudi blood donors (BD), 96 CAD patients, and 40 control subjects who had undergone angiography. Compared to controls, only epsilon4 was elevated in CAD patients. More than 61% (P <.0001) of the patients had angina, and 52.1% (P <.05) were diabetic; both of these factors were strongly associated with the presence of allele epsilon2. The epsilon2 allele was also associated with hypertension, elevated serum triglycerides, and total cholesterol. On the other hand, the allele epsilon4 appeared to be associated with increased risk of CAD and was also associated with hypertension, 3-vessel disease, and restenosis.
CONCLUSIONS: Accordingly, epsilon4 may be associated with increased risk of CAD, whereas epsilon2 appears to be a predictor of several risk factors for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583930     DOI: 10.5858/1999-123-1241-ROAEPF

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations.

Authors:  K K Abu-Amero; T M Bosley
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip.

Authors:  Lamia F Abu Marrzoq; Fadel A Sharif; Abdalla A Abed
Journal:  J Cardiovasc Dis Res       Date:  2011-01

3.  Increased Risk of the APOB rs11279109 Polymorphism for CHD among the Kuwaiti Population.

Authors:  Suzanne A Al-Bustan; Fatma G Ismael; Ahmad Al-Serri; Ibrahim Al-Rashdan
Journal:  Dis Markers       Date:  2017-12-06       Impact factor: 3.434

4.  Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study.

Authors:  Manal S Fawzy; Eman A Toraih; Nagwa M Aly; Abeer Fakhr-Eldeen; Dahlia I Badran; Mohammad H Hussein
Journal:  BMC Cardiovasc Disord       Date:  2017-01-13       Impact factor: 2.298

5.  Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan.

Authors:  Laith N Al-Eitan; Ayah Y Almasri; Adan H Alnaamneh; Hatem A Aman; Nasr N Alrabadi; Rame H Khasawneh; Mansour A Alghamdi
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

6.  Association of Apolipoprotein E Polymorphism with Adipokines and Cardiovascular Disease Risk in Rheumatoid Arthritis Patients.

Authors:  Yi-Ming Chen; Po-Ku Chen; Ching-Kun Chang; Chi-Chen Lin; Hsin-Hua Chen; Joung-Liang Lan; Shih-Hsin Chang; Der-Yuan Chen
Journal:  Life (Basel)       Date:  2020-12-07

7.  Apolipoprotein E polymorphism and lipoprotein levels in a Gulf Arab population in Kuwait: a pilot study.

Authors:  S Al-Shammari; H Fatania; R Al-Radwan; A O Akanji
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.